Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wolters-kluwer-health/prevention-of-atrial-fibrillation-by-way-of-abrogation-of-the-renin-ySWNrTTN5I
References (47)
-
Y. Zou, I. Komuro, T. Yamazaki, S. Kudoh, R. Aikawa, Weidong Zhu, I. Shiojima, Y. Hiroi, K. Tobe, T. Kadowaki, Y. Yazaki (1998)
Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts.Circulation research, 82 3
-
Swedberg, Marc Pfeffer, Alain Cohen-Solal, et al. Prevention of atrial fibrillation in symptomatic chronic heart failure by candesartan: results from the CHARM study [Abstract].
J Am Coll Cardiol, 43
-
Alsheikh-Ali (2004)
Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.Am Heart J, 147
-
A. Goette, Gina Juenemann, B. Peters, H. Klein, A. Roessner, C. Huth, C. Röcken (2002)
Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery.Cardiovascular research, 54 2
-
L. Hansson, L. Lindholm, T. Ekbom, B. Dahlöf, J. Lanke, B. Scherstén, P. Wester, T. Hedner, U. Faire (1999)
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 studyThe Lancet, 354
-
K. Ueng, T. Tsai, Wen-Chung Yu, Chin-Feng Tsai, Ming-cheng Lin, Kuei‐Chuan Chan, C. Chen, Der-Jinn Wu, Chung‐Sheng Lin, Shih‐Ann Chen (2003)
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study.European heart journal, 24 23
-
M. Weber, S. Julius, S. Kjeldsen, Hans Brunner, S. Ekman, L. Hansson, T. Hua, J. Laragh, G. Mcinnes, Lada Mitchell, F. Plat, M. Schork, Beverly Smith, A. Zanchetti (2004)
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE TrialThe Lancet, 363
-
M. Wijffels, C. Kirchhof, R. Dorland, M. Allessie (1995)
Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.Circulation, 92 7
-
Madrid (2002)
Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.Circulation, 106
-
Danshi Li, S. Fareh, T. Leung, S. Nattel (1999)
Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.Circulation, 100 1
-
A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M. Russo, A. Maseri (1997)
Histological substrate of atrial biopsies in patients with lone atrial fibrillation.Circulation, 96 4
-
K. Swedberg, M. Pfeffer, A. Cohen-Solal, A. Ducharme, C. Granger, E. Michelson, J. McMurray, James Young, S. Yusuf (2004)
1145-122 Prevention of atrial fibrillation in symptomatic chronic heart failure by candesartan: Results from CHARMJournal of the American College of Cardiology, 43
-
Danshi Li, K. Shinagawa, Li Pang, T. Leung, Sophie Cardin, Zhiguo Wang, S. Nattel (2001)
Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart FailureCirculation: Journal of the American Heart Association, 104
-
F. Pizzetti, F. Turazza, M. Franzosi, S. Barlera, A. Ledda, A. Maggioni, L. Santoro, G. Tognoni (2001)
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 dataHeart, 86
-
A. Goette, Philipp Hoffmanns, Wafa Enayati, U. Meltendorf, J. Geller, Helmut Klein (2001)
Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation.The American journal of cardiology, 88 8
-
Y. Hirayama, H. Atarashi, Yoshinori Kobayashi, T. Horie, Y. Iwasaki, M. Maruyama, Y. Miyauchi, T. Ohara, M. Yashima, T. Takano (2005)
Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation.Circulation journal : official journal of the Japanese Circulation Society, 69 6
-
J. Healey, A. Baranchuk, E. Crystal, C. Morillo, M. Garfinkle, S. Yusuf, S. Connolly (2005)
Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-AnalysisJournal of the American College of Cardiology, 45
-
A. Zaman, M. Kearney, C. Schecter, S. Worthley, J. Nolan (2004)
Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation.American heart journal, 147 5
-
A. Madrid, M. Bueno, J. Rebollo, I. Marín, G. Peña, E. Bernal, Aníbal Rodríguez, L. Cano, J. Cano, P. Cabeza, C. Moro (2002)
Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized StudyCirculation: Journal of the American Heart Association, 106
-
M. Wijffels, C. Kirchhof, R. Dorland, J. Power, M. Allessie (1997)
Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation.Circulation, 96 10
-
Post - hoc analysis suggests valsartan reduces new AF in patients with heart failure -
C. Kolb, Susanna Nürnberger, G. Ndrepepa, B. Zrenner, A. Schömig, C. Schmitt (2001)
Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system.The American journal of cardiology, 88 8
-
O. Pedersen, H. Bagger, L. Køber, C. Torp-Pedersen (1999)
The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution.European heart journal, 20 10
-
Y. Zou, I. Komuro, T. Yamazaki, S. Kudoh, R. Aikawa, Weidong Zhu, I. Shiojima, Y. Hiroi, K. Tobe, T. Kadowaki, Y. Yazaki (1998)
Cell Type–Specific Angiotensin II–Evoked Signal Transduction PathwaysCirculation Research, 82
-
M. Webster, M. Fitzpatrick, M. Nicholls, H. Ikram, J. Wells (1985)
Effect of enalapril on ventricular arrhythmias in congestive heart failure.The American journal of cardiology, 56 8
-
Ueng (2003)
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation Results of a prospective and controlled study.Eur Heart J, 24
-
Yao Sun, F. Ramires, K. Weber (1997)
Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion.Cardiovascular research, 35 1
-
L. Hansson, L. Lindholm, L. Niskanen, J. Lanke, T. Hedner, A. Niklason, K. Luomanmäki, B. Dahlöf, U. Faire, C. Mörlin, B. Karlberg, P-O Wester, Jan-Erik Björck (1999)
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trialThe Lancet, 353
-
Masahiko Yano, Shokei Kim, Y. Izumi, S. Yamanaka, H. Iwao (1998)
Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension.Circulation research, 83 7
-
Andrew Allen, Jialong Zhuo, F. Mendelsohn (1999)
Localization of angiotensin AT1 and AT2 receptors.Journal of the American Society of Nephrology : JASN, 10 Suppl 11
-
R. Touyz, P. Sventek, R. Lariviere, G. Thibault, J. Fareh, T. Reudelhuber, E. Schiffrin (1996)
Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors.Hypertension, 27 5
-
H. Lithell, L. Hansson, I. Skoog, D. Elmfeldt, A. Hofman, B. Olofsson, P. Trenkwalder, A. Zanchetti (2003)
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trialJournal of Hypertension, 21
-
E. Vermes, J. Tardif, M. Bourassa, N. Racine, S. Lévesque, M. White, P. Guerra, A. Ducharme (2003)
Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) TrialsCirculation, 107
-
P. L'allier, A. Ducharme, P. Keller, Holly Yu, M. Guertin, J. Tardif (2004)
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.Journal of the American College of Cardiology, 44 1
-
H. Nakashima, K. Kumagai, H. Urata, N. Gondo, M. Ideishi, Kikuo Arakawa (2000)
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation.Circulation, 101 22
-
K. Wachtell, M. Lehto, E. Gerdts, M. Olsen, B. Hornestam, B. Dahlöf, H. Ibsen, S. Julius, S. Kjeldsen, L. Lindholm, M. Nieminen, R. Devereux (2005)
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.Journal of the American College of Cardiology, 45 5
-
W. Kannel, P. Wolf, E. Benjamin, D. Lévy (1998)
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.The American journal of cardiology, 82 8A
-
F. Ravelli, M. Allessie (1997)
Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart.Circulation, 96 5
-
A. Goette, M. Arndt, Christoph Röcken, Antje Spiess, T. Staack, J. Geller, C. Huth, S. Ansorge, Helmut Klein, U. Lendeckel (2000)
Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans.Circulation, 101 23
-
M. Berg, Harry Cruns, D. Veldhuisen, Nico Griep, P. Kam, K. Lie (1995)
Effects of lisinopril in patients with heart failure and chronic atrial fibrillation.Journal of cardiac failure, 1 5
-
Fuster (2001)
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary-a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology.Circulation, 104
-
A. Goette, T. Staack, Christoph Röcken, M. Arndt, J. Geller, C. Huth, S. Ansorge, Helmut Klein, U. Lendeckel (2000)
Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.Journal of the American College of Cardiology, 35 6
-
FIGURE 1. Effect of treatment on atrial fibrillation based on class of drug -
Gruppo Miocardico. (1994)
GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarctionThe Lancet, 343
-
T. Noord, H. Crijns, M. Berg, D. Veldhuisen, I. Gelder (2005)
Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillationBMC Cardiovascular Disorders, 5
-
A. Alsheikh-Ali, Paul Wang, W. Rand, M. Konstam, M. Homoud, M. Link, N. Estes, D. Salem, A. Al‐Ahmad (2003)
Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.American heart journal, 147 6
-
V. Fuster, Lars Rydén, Richard Asinger, Davis Cannom, H. Crijns, Robert Frye, J. Halperin, G. Kay, Werner Klein, Samuel Levy, Robert McNamara, E. Prystowsky, L. Wann, D. Wyse, R. Gibbons, E. Antman, Joseph Alpert, D. Faxon, G. Gregoratos, L. Hiratzka, A. Jacobs, Richard Russell, Sidney Smith, Ángeles Alonso-García, Carina Blomström-Lundqvist, G. Backer, Marcus Flather, Jaromír Hradec, A. Oto, Alexander Parkhomenko, S. Silber, A. Torbicki (2001)
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy ConferenceCirculation, 104 17
- Copyright
- Copyright © 2008 by Lippincott Williams & Wilkins
- ISSN
- 1075-2765
- eISSN
- 1536-3686
- DOI
- 10.1097/MJT.0b013e31804beb59
- pmid
- 18223352
- Publisher site
- See Article on Publisher Site
Abstract
American Journal of Therapeutics 15, 36–43 (2008) Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis Mhamad B. Jibrini, MD, Janos Molnar, MD, and Rohit R. Arora, MD, FACC* The renin-angiotensin-aldosterone system (RAAS) has emerged as an important hormonal system in the initiation and pathogenesis of atrial fibrillation (AF). Therefore, angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) are emerging as novel drugs for the prevention of AF. A meta-analysis of 11 randomized, controlled, parallel-design clinical trials evaluating effect of ACEIs or ARBs on the development of AF was performed. Treatment with ACEIs or ARBs reduced the relative risk (RR) of AF in patients with hypertension by 23% [RR 0.769, P , 0.001, 95% confidence interval (CI) 0.686–0.862] and by 11% in patients after myocardial infarction (RR 0.898, P , 0.05, 95% CI 0.814–0.992). Reduction in AF was greatest in patients after electrical cardioversion (RR 0.491, P , 0.001, 95% CI 0.334–0.720) and in patients with heart failure (RR 0.684, P , 0.001, 95% CI 0.594–0.787). Overall, inhibition of the RAAS reduced the RR of AF by 19% (RR 0.810, P , 0.001, 95% CI 0.759–0.865). Keywords: atrial fibrillation, renin,
Journal
American Journal of Therapeutics – Wolters Kluwer Health
Published: Jan 1, 2008